Immune Pharmaceuticals to transfer common stock listing from NASDAQ OMX Stockholm Exchange

Download PDF Copy

Reviewed

Immune Pharmaceuticals Inc.Nov 26 2013

Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that its common stock has been approved for trading on NASDAQ OMX First North Premier, Stockholm ("First North"). The Company will transfer its common stock listing from the NASDAQ OMX Stockholm Exchange on November 29, 2013, and the first day of trading on First North will be December 2, 2013.

Erik Penser Bankaktiebolag is engaged as Immune´s Certified Adviser on First North. A Company description has been prepared in accordance with First North´s rules and will be made available on Immune´s website.

Source:

Immune Pharmaceuticals Inc.

Posted in: Business / Finance

Comments (0)

Download PDF Copy

Suggested Reading

International commission calls for action against hepatocellular carcinoma

Edible microbeads trap fat to support weight loss

New study reveals long road to seizure control for people with focal epilepsy

Targeting gut signaling protein may protect against alcohol-related liver damage

Rising liver cancer rates highlight need for urgent action worldwide

Hypothalamic neurons help maintain blood sugar during daily activities

New treatment approach developed to prevent lupus nephritis

University of Vienna team develops method to measure molecular charges

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.